AIF1 and amyotrophic lateral sclerosis: In contrast, 12-month-old GNX-4728-treated ALS mice had significant preservation of motor neurons (Figures 3C,D) and significantly attenuated inflammation as evidenced by the diminished Iba1 immunoreactivity (Figures 3F–H).